Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database-Reference-Cited by-同舟云学术

Effect of sorafenib starting dose and dose intensity on survival in patients with hepatocellular carcinoma: Results from a Canadian Multicenter Database

Published:2020-06-11 Issue:14 Volume:9 Page:4918-4928
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Alghamdi Mohammed A.¹²,Amaro Carla P.¹^ORCID,Lee‐Ying Richard¹,Sim Hao‐Wen³,Samwi Haider⁴,Chan Kelvin K.⁵⁶,Knox Jennifer J.³,Ko Yoo‐Joung⁵,Swiha Mina⁷⁸,Batuyong Eugene¹,Romagnino Adriana⁵,Cheung Winson Y.¹,Tam Vincent C.¹^ORCID,

Affiliation:

1. Tom Baker Cancer Centre University of Calgary Calgary AB Canada

2. College of Medicine King Saud University Riyadh Saudi Arabia

3. Princess Margaret Cancer Centre University of Toronto Toronto ON Canada

4. St. Michael's HospitalUniversity of Toronto Toronto ON Canada

5. Sunnybrook Odette Cancer Centre Toronto ON Canada

6. Canadian Centre for Applied Research in Cancer Control Toronto ON Canada

7. University of Western Ontario London ON Canada

8. Menoufia University Shebin El Kom Egypt

Funder

Tom Baker Cancer Centre Clinical Research Unit Grant

Publisher